Inside Guinea's Troubled Early Response to Ebola | FRONTLINE
Inside Guinea's Troubled Early Response to Ebola | FRONTLINE
Subscribe on YouTube: http://bit.ly/1BycsJWIn March of 2014, the mysterious and deadly disease that had been spreading in Guinea's forest region was officially confirmed as Ebola. But as FRONTLINE reveals, Guinea's government, the World Health Organization, and Doctors Without Borders were at odds about the scale of response that was necessary.
Watch the full film, OUTBREAK, here beginning May 5, 2015: http://www.pbs.org/wgbh/pages/frontline/outbreak/
Follow FRONTLINE:
Twitter: https://twitter.com/frontlinepbs
Facebook: https://www.facebook.com/frontline
Instagram: https://www.instagram.com/frontlinepbs
FRONTLINE is streaming more than 180 films online, for free here: http://to.pbs.org/hxRvQP
Funding for FRONTLINE's YouTube channel is provided by the Knight Foundation. FRONTLINE is made possible by PBS and CPB. Major support is provided by The John D. and Catherine T. MacArthur Foundation. Additional support is provided by the Park Foundation, the Ford Foundation, the Wyncote Foundation and Jon and Jo Ann Hagler on behalf of the Jon L. Hagler Foundation.
Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.